Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bodyguard
- Development stage
- Unknown
- Lead developer
- Pantex Holland
- Administration
- Oral
01
Overview
Bodyguard is a veterinary botanical formulation developed by Pantex Holland, specifically designed for use in pigeons and cage birds. The product contains *Echinacea pallida* extract at a concentration of 7.5 mg/mL, which acts as an immunostimulant to enhance the natural resistance of birds against bacterial and viral infections. In addition to the herbal active ingredient, the formulation includes organic acids, specifically acetic acid glacial and propionic acid, which serve as preservatives and help maintain a low pH in the gastrointestinal tract to inhibit the growth of pathogenic bacteria. Bodyguard is typically administered via drinking water to improve the overall condition and immune response of birds, particularly during periods of stress, recovery, or high disease pressure.
- Brand names
- Bodyguard
Beyond the preview
Go deeper on Bodyguard.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bodyguard.